Last reviewed · How we verify
NCT05803473: DIATEC
DIAbetes TEam and Cgm in Managing Hospitalised Patients with Diabetes
NA trial testing Dexcom G6 Continuous Glucose Monitoring System (Dexcom Inc., San Diego, USA) in Diabetes Mellitus, Type 2 in 166 participants. Completed in 29 July 2024.
29 March 2024
Quick facts
| Lead sponsor | Peter Kristensen |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 166 |
| Start date | 11 April 2023 |
| Primary completion | 29 March 2024 |
| Estimated completion | 29 July 2024 |
| Sites | 2 locations across Denmark |
Drugs / interventions tested
- Dexcom G6 Continuous Glucose Monitoring System (Dexcom Inc., San Diego, USA)
- FreeStyle Precision Pro Glucometer for glucose POC testing
Conditions studied
- Diabetes Mellitus, Type 2 — all drugs for Diabetes Mellitus, Type 2 →
Sponsor
Peter Kristensen
Who can join
18 and older, any sex, with Diabetes Mellitus, Type 2. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This trial investigates the effects of continuous glucose monitoring (CGM) and an in-hospital diabetes team on in-hospital glycemic and clinical outcomes in patients with type 2 diabetes compared to standard glucose point-of-care (POC) testing and an in-hospital diabetes team.
Publications & conference data
4 peer-reviewed publications reference this trial (live from Europe PMC):
-
Summary of clinical investigation plan for The DIATEC trial: in-hospital diabetes management by a diabetes team and continuous glucose monitoring or point of care glucose testing - a randomised controlled trial.
Olsen MT, Klarskov CK, Pedersen-Bjergaard U, Hansen KB, et al · · 2024 · cited 15× · PMID 38711112 · DOI 10.1186/s12902-024-01595-4 -
Time at High Risk of Hypoglycemia: Validation of a Consensus-Based Continuous Glucose Monitoring-Metric for Hospitalized Patients.
Olsen MT, Hansen KB, Pedersen-Bjergaard U, Kristensen PL. · · 2025 · cited 2× · PMID 40219621 · DOI 10.1177/19322968251331600 -
Evaluation of a Continuous Glucose Monitoring-Based Insulin Titration Protocol for Inpatients With Type 2 Diabetes in Nonintensive Care Unit Settings.
Olsen MT, Pedersen-Bjergaard U, Jensen SH, Rasmussen LM, et al · · 2025 · cited 2× · PMID 40186499 · DOI 10.1177/19322968251331628 -
Glycemic Levels and Insulin Use Daily and During Hospital Shifts in Hospitalized Patients With Type 2 Diabetes.
Olsen MT, Jensen SH, Rasmussen LM, Klarskov CK, et al · · 2025 · PMID 40980547 · DOI 10.1210/jendso/bvaf137
Verify or expand the search:
- PubMed search for NCT05803473
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetes Mellitus, Type 2
Currently open trials in the same condition.
- NCT07415954 — A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 · Phase 2 · recruiting
- NCT07532863 — A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Part · recruiting
- NCT07336329 — Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use · NA · recruiting
- NCT07242469 — A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006) · Phase 1 · recruiting
- NCT07444203 — Transformative Research in Diabetic Nephropathy 2.0 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05803473 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Peter Kristensen
- Last refreshed: 26 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05803473.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing